Full details, including potential risk factors, are given in the Press Release, which can be consulted by clicking on the link below
Nicox Announces up to €3 million in Milestone Payments from Kowa in 2025 as NCX 470 Prepares to Enter Phase 3 Clinical Trials in Japan

May 27, 2025

View Press Release Corporate presentation Contact us
Previous